Objective: To describe personnel experience with three unusual cases of low-grade adenosquamous carcinoma of the breast. Due to the aggressive course in two cases, the review of the literature does not concentrate on morphology and differential diagnosis only, but discuss overall biology of this lesion too.

Design: Three case reports.

Setting: Biopsy Lab s.r.o. and Sikl's Department of Pathology, Charles University and Faculty Hospital, Pilsen.

Methods: Included are cases from mammary register of Biopsy Lab s.r.o. and from personnel consulting registry of Prof. Michal. In details are documented both clinical presentations, including follow up, and spectrum of histologic patterns of the lesion. Immunohistochemistry performed by streptavidin-biotin system (LSAB+, Dako) as detection system and diaminobenzidin tetrahydrochlorid as chromogen, employed standard myoepitelial markers (actin, CD10, calponin and p63), hormonal receptors, oncogen Her-2/neu, CK7, CAM5.2, CD34 and CD117.

Results: Partial mastectomy and segmentectomy were performed in three women 46, 72 and 74 years-old resp. for tumor, which size ranged from 20-35 mm in maximum diameter (mean 28 mm). Histology revealed low-grade adenosquamous metaplastic carcinoma displaying typical biphasic appearance combining regular tubular structures with surrounding storiform, sclerosing fibrous stroma. Variably present was characteristic squamous metaplasia of the gland forming either luminal morules or evident squamous pearls. Using immunohistochemistry, a total absence of myoepithelial layer in epithelial structures was confirmed. The stromal component expressed smooth muscle actin in two cases, one of which contained areas of heterologous chondrosseal differentiation. There were recognized metastases by one woman in two ipsilateral axillary lymph nodes mimicking benign breast heterotopia in one of them. One patient experienced recurrence in the scar 37 months after mastectomy where only mesenchymal heterologous component element was found. In two women with aggressive course the original biopsy was falsely interpreted, once as phyllodes tumor and secondly as benign sclerosing pseudotumor.

Conclusion: low-grade adenosquamous carcinoma, despite its bland histology, should be understood as regular malignancy prone to frequent recurrences and recognized metastatic potential. It arises in the deep breast tissue and structurally resembles the microcystic adnexal carcinoma of the skin. Low-grade adenosquamous carcinoma, however, has nothing to do with syringomatous adenoma of the nipple, which is a benign tumor of the skin adnexa. Differential diagnosis includes spectrum of non-neoplastic slerosing lesions and above-mentioned phylloid tumor. The rarity of this neoplasm does not exclude deep knowledge.

Download full-text PDF

Source

Publication Analysis

Top Keywords

low-grade adenosquamous
16
adenosquamous carcinoma
12
adenosquamous metaplastic
8
cases review
8
aggressive course
8
differential diagnosis
8
biopsy lab
8
lab sro
8
adenosquamous
5
cases
5

Similar Publications

(1) Low-grade adenosquamous carcinoma (LGASC) is a rare subtype of metaplastic breast carcinoma (MpBC), accounting for fewer than 0.05% of breast cancer cases. Unlike the typically aggressive nature of MpBCs, LGASC is an indolent tumor with an excellent prognosis.

View Article and Find Full Text PDF

Rationale: Breast low-grade adenosquamous carcinoma is an uncommon cancer that has been neglected in genetic and pathophysiological research. Consequently, medical practitioners face challenges in the effective diagnosis and treatment of this condition.

Patient Concerns: We present the case of a 57-year-old Asian female patient who presented with bilateral breast masses on physical examination.

View Article and Find Full Text PDF
Article Synopsis
  • Diagnosing low-grade adenosquamous carcinoma (LGASC) is challenging due to its subtle appearance and similarity to benign conditions, making identification difficult.
  • A 53-year-old woman initially diagnosed with a benign growth underwent a wider excision, which unexpectedly revealed LGASC with some expression of estrogen receptors.
  • The case underscores the diagnostic difficulties associated with LGASC, particularly when relying on small tissue samples from biopsies.
View Article and Find Full Text PDF

Nonneoplastic and neoplastic sclerosing lesions of the breast.

Histopathology

September 2024

Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Article Synopsis
  • Sclerosing lesions of the breast are both benign and malignant and can be challenging to diagnose, requiring awareness of key characteristics to avoid misdiagnosis.
  • The review highlights nonneoplastic sclerosing lesions, providing details on their clinical presentation, morphology, diagnostic considerations, and necessary immunohistochemical tests.
  • It also briefly discusses atypical or neoplastic entities related to these lesions, emphasizing the importance of accurate diagnosis for effective clinical management.
View Article and Find Full Text PDF
Article Synopsis
  • * The study analyzed 347 male patients, predominantly white, with median ages of 70, highlighting that EA had the longest median overall survival (62.9 months) compared to GEJA (33.4 months) and GA (38.1 months).
  • * Prognostic factors that impacted survival include tumor location, size, differentiation, subtype, and TNM stage, with the research further categor
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!